Actively Recruiting
Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM
Led by Anna Stanhewicz, PhD · Updated on 2025-12-09
40
Participants Needed
1
Research Sites
134 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Women with a history of gestational diabetes mellitus (GDM) are at a 2-fold greater risk for the development of overt cardiovascular disease (CVD) following the effected pregnancy. While subsequent development of type II diabetes elevates this risk, prior GDM is an independent risk factor for CVD morbidity, particularly, within the first decade postpartum. GDM is associated with impaired endothelial function during pregnancy and decrements in macro- and microvascular function persist postpartum, despite the remission of insulin resistance following delivery. Collectively, while the association between GDM and elevated lifetime CVD risk is clear, and available evidence demonstrates a link between GDM and vascular dysfunction in the decade following pregnancy, the mechanisms mediating this persistent dysfunction remain unexamined. The purpose of this investigation is to examine the role of endothelin-1, a potent vasoconstrictor, in aberrant microvascular function in otherwise healthy women with a history of GDM and to identify whether this mechanism is influenced by physical activity and sedentary behavior.
CONDITIONS
Official Title
Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM
Who Can Participate
Eligibility Criteria
You may qualify if you...
- History of pregnancy within 5 years of the study visit
- Had either a healthy pregnancy or gestational diabetes diagnosed by an obstetrician and confirmed by American College of Obstetricians and Gynecologists criteria
You will not qualify if you...
- Presence of skin diseases
- Current use of tobacco or electronic cigarettes/vape pens
- Diagnosed or suspected liver or metabolic diseases including diabetes
- Use of statins or other cholesterol-lowering medications
- Current use of antihypertensive medications
- History of preeclampsia or gestational hypertension
- Current hypertension
- Current pregnancy
- Body mass index less than 18.5 kg/m2
- Allergy to materials used during the experiment such as latex or allergies to study drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Iowa
Iowa City, Iowa, United States, 52242
Actively Recruiting
Research Team
A
Anna Reid-Stanhewicz, PHD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here